- Home
- EPAM vs RGEN Comparison
EPAM vs RGEN Comparison
Compare EPAM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAM
- RGEN
- Stock Information
- Founded
- EPAM 1993
- RGEN 1981
- Country
- EPAM United States
- RGEN United States
- Employees
- EPAM N/A
- RGEN N/A
- Industry
- EPAM EDP Services
- RGEN Medical/Dental Instruments
- Sector
- EPAM Technology
- RGEN Health Care
- Exchange
- EPAM Nasdaq
- RGEN Nasdaq
- Market Cap
- EPAM 8.2B
- RGEN 8.0B
- IPO Year
- EPAM 2012
- RGEN N/A
- Fundamental
- Price
- EPAM $183.88
- RGEN $128.01
- Analyst Decision
- EPAM Buy
- RGEN Buy
- Analyst Count
- EPAM 16
- RGEN 12
- Target Price
- EPAM $229.00
- RGEN $172.67
- AVG Volume (30 Days)
- EPAM 702.9K
- RGEN 847.4K
- Earning Date
- EPAM 05-08-2025
- RGEN 04-29-2025
- Dividend Yield
- EPAM N/A
- RGEN N/A
- EPS Growth
- EPAM N/A
- RGEN N/A
- EPS
- EPAM 7.15
- RGEN N/A
- Revenue
- EPAM $4,864,167,000.00
- RGEN $650,429,000.00
- Revenue This Year
- EPAM $14.70
- RGEN $13.93
- Revenue Next Year
- EPAM $7.82
- RGEN $14.35
- P/E Ratio
- EPAM $26.15
- RGEN N/A
- Revenue Growth
- EPAM 4.72
- RGEN 4.88
- 52 Week Low
- EPAM $138.15
- RGEN $102.97
- 52 Week High
- EPAM $269.00
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- EPAM 65.45
- RGEN 45.14
- Support Level
- EPAM $156.21
- RGEN $123.10
- Resistance Level
- EPAM $189.62
- RGEN $135.47
- Average True Range (ATR)
- EPAM 4.52
- RGEN 6.76
- MACD
- EPAM 4.50
- RGEN -0.72
- Stochastic Oscillator
- EPAM 84.08
- RGEN 20.37
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.